ActivX Biosciences Appoints Former Bayer Exec as VP of Chemistry | GenomeWeb

NEW YORK, May 24 - Proteomics startup ActivX Biosciences has appointed David Campbell, formerly director of discovery chemistry at Bayer, to the position of vice president of chemistry, the company said Thursday. 

At ActivX Campbell will be responsible for overseeing all chemistry programs at the company. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.